Bioprinting for Cell Delivery Using Cell-adaptive Hydrogel

Cell-based therapeutics have emerged as a promising approach for the treatment of major diseases. However, existing cell-based therapies often face challenges, including low cell survival rates in vivo and high treatment costs. Biomaterials provide an effective means of modulating the cellular microenvironment, and their application in cell delivery offers a strategy for developing future cell-based therapeutics. In this study, we developed light-based fast bioprinting technologies and nanostructured cell-adaptive hydrogels for creating novel cell delivery system. Our work would inspire the development of novel cell-based therapeutic technologies.

Dr. Maling Gou is a full professor in the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, China. His research mainly focuses on bioprinting and biomaterials for biotherapy. He has developed digital light processing (DLP)-based 3D printing technologies and biomaterials-enabled or -improved therapeutics for potential application in cancer treatment and tissue regeneration. He published over 100 academic papers in various international journals and has been selected as the associate editor and editorial board member for some international academic journals, such as International Journal of Bioprinting, Int. J. Nanomed., BURNS TRAUMA, and Bio-Des. Manuf.. Now, he is the chairman of 3D Printing Technology Branch of the China Medical Biotechnology Association (CMBA) and the vice-chairman of Disease Model Technology Branch of the CMBA.